False Claim Not Apparent To 2nd Circ. In Lipitor Suit
By Pete Brush ( December 7, 2015, 3:59 PM EST) -- The Second Circuit struggled Monday to determine where a false claim for reimbursement may have been submitted for Pfizer's anti-cholesterol drug Lipitor as a plaintiff sought to revive his decade-old qui tam suit alleging the drug giant's massive ad campaign led to Medicare and Medicaid overcharges....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.